Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 4
2011 3
2012 2
2013 2
2014 2
2015 5
2016 2
2017 10
2018 6
2019 9
2020 11
2021 21
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Hailemichael Y, et al. Cancer Cell. 2022 May 9;40(5):509-523.e6. doi: 10.1016/j.ccell.2022.04.004. Epub 2022 May 9. Cancer Cell. 2022. PMID: 35537412 Free PMC article.
IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.
Delyon J, Lebbe C. Delyon J, et al. Cancer Cell. 2022 May 9;40(5):450-451. doi: 10.1016/j.ccell.2022.04.010. Epub 2022 May 9. Cancer Cell. 2022. PMID: 35537409 Free article.
Increasing the efficacy of immune checkpoint blockade therapy while mitigating toxicity is one of the major challenges in oncology research. In this issue of Cancer Cell, Hailemichael et al. provide a strong rationale for the combination of IL-6 blockade and dual inhibitio …
Increasing the efficacy of immune checkpoint blockade therapy while mitigating toxicity is one of the major challenges in oncology research. …
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
Hickman A, Koetsier J, Kurtanich T, Nielsen MC, Winn G, Wang Y, Bentebibel SE, Shi L, Punt S, Williams L, Haymaker C, Chesson CB, Fa'ak F, Dominguez AL, Jones R, Kuiatse I, Caivano AR, Khounlo S, Warier ND, Marathi U, Market RV, Biediger RJ, Craft JW Jr, Hwu P, Davies MA, Woodside DG, Vanderslice P, Diab A, Overwijk WW, Hailemichael Y. Hickman A, et al. J Clin Invest. 2022 Jul 1;132(13):e154152. doi: 10.1172/JCI154152. J Clin Invest. 2022. PMID: 35552271 Free PMC article.
Symptomatic Double Aortic Arch Anomaly.
Lakhani DA, Moore F, Hailemichael E. Lakhani DA, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):e55-e56. doi: 10.1016/j.cgh.2020.04.015. Epub 2020 Apr 11. Clin Gastroenterol Hepatol. 2021. PMID: 32289546 Free PMC article. No abstract available.
Neopterin: A Promising Candidate Biomarker for Severe COVID-19.
Hailemichael W, Kiros M, Akelew Y, Getu S, Andualem H. Hailemichael W, et al. J Inflamm Res. 2021 Feb 2;14:245-251. doi: 10.2147/JIR.S290264. eCollection 2021. J Inflamm Res. 2021. PMID: 33564258 Free PMC article. Review.
Intractable Cough Associated With Renal Cell Carcinoma.
Singh A, Everest S, Nguyen L, Hailemichael T. Singh A, et al. Cureus. 2021 Oct 12;13(10):e18727. doi: 10.7759/cureus.18727. eCollection 2021 Oct. Cureus. 2021. PMID: 34796045 Free PMC article.
An Unusual Case of Small Bowel Obstruction.
Patel Z, Hailemichael E, Lakhani DA. Patel Z, et al. Gastroenterology. 2021 Jul;161(1):e4-e6. doi: 10.1053/j.gastro.2020.10.051. Epub 2020 Nov 20. Gastroenterology. 2021. PMID: 33221404 Free PMC article. No abstract available.
89 results